losartan and ru 28318
losartan has been researched along with ru 28318 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akhtar, S; Al-Rashdan, I; Babiker, F; Benter, IF; Yousif, M | 1 |
Other Studies
1 other study(ies) available for losartan and ru 28318
| Article | Year |
|---|---|
RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Spironolactone | 2013 |